Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hardwick

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 11, 2012
Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Daniel W Ferreira, Vijay R More, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Altered arsenic disposition in experimental nonalcoholic fatty liver diseaseMark J Canet, Rhiannon N Hardwick, April D Lake, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2022
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical SpeciesRhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Bioengineering (Basel, Switzerland)|October 28, 2023
Reproducibility and Robustness of a Liver Microphysiological System PhysioMimix LC12 under Varying Culture Conditions and Cell Type CombinationsAlicia Y Lim, Yuki Kato, Courtney Sakolish, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 2, 2014
Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitisRhiannon N Hardwick, John D Clarke, April D Lake, et al.
ALTEX|July 30, 2025
Pharmaceutical industry perspective on the utility of animal cell-based microphysiological systems to support human drug developmentPatrick J Devine, Jason Ekert, Anna K Kopec, et al.
Journal of Proteome Research|June 17, 2020
A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague-Dawley RatsMarine P M Letertre, Nyasha Munjoma, Kate Wolfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2015
Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitisMark J Canet, Matthew D Merrell, Rhiannon N Hardwick, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 11, 2022
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing ConsortiumIvan Rusyn, Courtney Sakolish, Yuki Kato, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 11, 2012
Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Daniel W Ferreira, Vijay R More, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Altered arsenic disposition in experimental nonalcoholic fatty liver diseaseMark J Canet, Rhiannon N Hardwick, April D Lake, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 8, 2022
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical SpeciesRhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2018
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancersV Chung, F J Kos, N Hardwick, et al.
Bioengineering (Basel, Switzerland)|October 28, 2023
Reproducibility and Robustness of a Liver Microphysiological System PhysioMimix LC12 under Varying Culture Conditions and Cell Type CombinationsAlicia Y Lim, Yuki Kato, Courtney Sakolish, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 2, 2014
Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitisRhiannon N Hardwick, John D Clarke, April D Lake, et al.
ALTEX|July 30, 2025
Pharmaceutical industry perspective on the utility of animal cell-based microphysiological systems to support human drug developmentPatrick J Devine, Jason Ekert, Anna K Kopec, et al.
Journal of Proteome Research|June 17, 2020
A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague-Dawley RatsMarine P M Letertre, Nyasha Munjoma, Kate Wolfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2015
Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitisMark J Canet, Matthew D Merrell, Rhiannon N Hardwick, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 11, 2022
Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing ConsortiumIvan Rusyn, Courtney Sakolish, Yuki Kato, et al.
Pageof 6